Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovex International (INVX) EBIT (2016 - 2026)

Innovex International filings provide 17 years of EBIT readings, the most recent being -$79.8 million for Q4 2025.

  • On a quarterly basis, EBIT fell 396.66% to -$79.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $27.0 million, a 45.0% decrease, with the full-year FY2025 number at $27.0 million, down 45.0% from a year prior.
  • EBIT hit -$79.8 million in Q4 2025 for Innovex International, down from $62.3 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $72.9 million in Q4 2022 to a low of -$79.8 million in Q4 2025.
  • Median EBIT over the past 5 years was $8.0 million (2022), compared with a mean of $4.0 million.
  • Biggest five-year swings in EBIT: crashed 520.51% in 2021 and later skyrocketed 599.84% in 2024.
  • Innovex International's EBIT stood at -$72.2 million in 2021, then soared by 201.0% to $72.9 million in 2022, then crashed by 68.02% to $23.3 million in 2023, then grew by 15.49% to $26.9 million in 2024, then tumbled by 396.66% to -$79.8 million in 2025.
  • The last three reported values for EBIT were -$79.8 million (Q4 2025), $62.3 million (Q3 2025), and $22.7 million (Q2 2025) per Business Quant data.